Prospective evaluation of Quality of Life in head and neck cancer patients treated with palliative radiotherapy

Recruiting

• Conditions: C00; C04; C09; C10; C11; C31; C01; C14; C32; C02

• Registration Number: DRKS00021197
• Lead Sponsor: niversitätsklinikum Schleswig-Holstein Campus Kiel

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

squamous cell head and neck cancer;
indication for palliative radiotherapy;
ability to fill out questionnaires;
age at least 18yrs;
informed consent

Exclusion Criteria

radiotherapy with curative intend (EQD2 = 60 Gy);
cutaneous primary; legal incapacity or missing informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life as measured by the questionnaires EORTC QLQ C-30+H&N43 before and after radiotherapy (descriptive statistics, but mandatory reporting of QoL domains global QoL, Pain - mouth, swallowing, Fatigue, and physical funtioning at 2 months after radiotherapy; the observation period will be from before the onset of radiotherapy to 12 months after radiotherapy in intervals)

Secondary Outcome Measures

Name	Time	Method
toxicity (CTCAE), frequency of unplanned hospital admissions, evolution of performance status and intake of analgesics, satisfaction with therapy, overall survival (the observation period will be from before the onset of radiotherapy to 18 months after radiotherapy in intervals)